| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000015196 |
| Receipt No. | R000017664 |
| Official scientific title of the study | The evaluation of nutritional recovery after open and laparoscopic gastrectomies for early gastric cancer |
| Date of disclosure of the study information | 2014/09/17 |
| Last modified on | 2017/09/20 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | The evaluation of nutritional recovery after open and laparoscopic gastrectomies for early gastric cancer | |
| Title of the study (Brief title) | CCOG1204 | |
| Region |
|
|
| Condition | ||
| Condition | Gastric cancer | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We will evaluate that the nutritional recovery after laparoscopic gastrectomies for gastric cancer patients who are diagnosed to be Stage 1A/1B is superior to after open gastrectomies |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Variation of the total amount of muscles 6 months after open and laparoscopic gastrectomy |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. Gastric cancer patients who are diagnosed to be Stage 1A/1B according to the Japanease classification for gastric cancer
2. Patients who are going to undergo distal gastrectomy |
|||
| Key exclusion criteria | 1) Synchronous or metachronous (within 5 years) malignancies other than carcinoma in situ
2) Body mass index more than 30 3) Uncontrollable hypertension or uncontrollable diabetes mellitus 4) Continuous systemic steroid therapy 5) Otherwise considered inadequate for inclusion in this trial by the physician |
|||
| Target sample size | 165 | |||
| Research contact person | |
| Name of lead principal investigator | Yasuhiro Kodera |
| Organization | Nagoya University, Graduate School of Medicine |
| Division name | Gastroenterorogical Surgery |
| Address | 65 Tsurumai-cho Showa-ku Nagoya city |
| TEL | 052-744-2253 |
| ykodera@med.nagoya-u.ac.jp | |
| Public contact | |
| Name of contact person | Hidenobu Matsushita |
| Organization | Tosei General Hospital |
| Division name | Surgery |
| Address | 160 Nishioiwake-cho Seto city |
| TEL | 0561-82-5101 |
| Homepage URL | |
| hidenobu@med.nagoya-u.ac.jp | |
| Sponsor | |
| Institute | Chubu Clinical Oncology Group |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Chubu Clinical Oncology Group |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | Key inclusion criteria:
1. Gastric cancer patients who are diagnosed to be Stage 1A/1B according to the Japanease classification for gastric cancer 2. Patients who are going to undergo distal gastrectomy Key exclusion criteria: 1) Synchronous or metachronous (within 5 years) malignancies other than carcinoma in situ 2) Body mass index more than 30 3) Uncontrollable hypertension or uncontrollable diabetes mellitus 4) Continuous systemic steroid therapy 5) Otherwise considered inadequate for inclusion in this trial by the physician |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000017664 |